NeuroRx
  • Home
  • About Us
  • Covid-19
  • NRX-100/101
  • News
  • Contact
  • Home
  • News
  • Houston

Tag: Houston

Press releases

Relief Therapeutics and NeuroRx Expand Clinical Trial Evaluating RLF-100 in Critically Ill COVID-19 Patients with Respiratory Failure to Houston Methodist Hospital

Clinical trial expanded to patients treated with both noninvasive and mechanical ventilation in Critical COVID-19.

Read more

Categories

  • Broadcasts
  • News
  • Press releases

Tags

ARDS Aviptadil Big Rock Partners Bipolar Depression Clinical Trials Covid-19 Emergency Use Expanded Access Fast Track FDA Houston I-Spy i24 News NASDAQ NRX-100/101 NRXP Orphan Drug Designation Respiratory Failure RLF-100 VIP Zysami

Developing innovative therapies for high-mortality unmet needs.

Company Info

  • About Us
  • RLF-100
  • NRX 100/101

Learn More

  • USA-Licensed Physicians
  • Investors
© 2020 NeuroRx, Inc.